Mesenchymal Stem Cells in Health and Disease
5 Articles
5 Articles
From the Age of 50, some Stem Cells Take Control of the Blood, Make It Lose Diversity, and We Are More Likely to Get Sick.
In the long run towards aging, some clones of stem cells in our body take control of blood production and others disappear or remain residual. The competition between stem cells makes us, as we turn old, the blood system alters and deteriorates, loses diversity, and we are more vulnerable to disease.
Mesenchymal stem cells in health and disease
Mesenchymal stem cells (MSCs) have been used in the clinic to treat some human conditions, but what effect do they have on the immune system? This article describes the immunomodulatory properties of MSCs and discusses how these findings can be translated to the clinic. Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be isolated from many adult tissues. They can differentiate into cells of the mesodermal l…
Osteogenic differentiation of human mesenchymal stem cells in freeze-gelled chitosan/nano β-tricalcium phosphate porous scaffolds crosslinked with genipin
The objective of this work was to investigate material properties and osteogenic differentiation of human mesenchymal stem cells (hMSCs) in genipin (G…
Mesenchymal Stem Cell-Mediated Mitochondrial Transfer Regulates the Fate of B Lymphocytes
The authors investigated signals that trigger mitochondrial transfer from MSCs to immune cells and evaluated its impact on the phenotype of recipient cells, with particular emphasis on B cells. [European Journal of Clinical Investigation] Full Article
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage